Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases.

Alam MJ, Yap YA, Ang C, Xie L, Shane HL, Mackay CR, Robert R

Open source

DOI
10.3389/fimmu.2025.1728419
Published
2025
Container
Frontiers in immunology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2025.1728419,
  title = {Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases.},
  author = {Alam MJ and Yap YA and Ang C and Xie L and Shane HL and Mackay CR and Robert R},
  year = {2025},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2025.1728419},
  url = {https://doi.org/10.3389/fimmu.2025.1728419}
}

RIS

TY  - JOUR
TI  - Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases.
AU  - Alam MJ
AU  - Yap YA
AU  - Ang C
AU  - Xie L
AU  - Shane HL
AU  - Mackay CR
AU  - Robert R
PY  - 2025
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2025.1728419
UR  - https://doi.org/10.3389/fimmu.2025.1728419
ER  - 

APA

MJ, A., YA, Y., C, A., L, X., HL, S., CR, M., & R, R. (2025). Fc-enhanced anti-CCR6 antibody elicits robust therapeutic effects across multiple autoimmune diseases.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2025.1728419

Source records